A prospective, open and controlled clinical study of traditional Chinese medicine (Astragalus / Panax notoginseng) combined with a new oncolytic vaccine in the treatment of Recurrent or Metastatic Colorectal Cancer

ABSTRACT: Interventions: Group 1:the new oncolytic vaccine;Group2:traditional Chinese medicine (A stragalus / Panax notoginseng)combined with the new oncolytic vaccine Primary outcome(s): Objective response rate;Safety index Study Design: Non randomized control

DISEASE(S): Colorectal Cancer

PROVIDER: 2698361 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR